title: Analytical and Clinical Validation of a Point-of-Care Cardiac Troponin T Test with an Improved Detection Limit.
abstract: BACKGROUND
  The point-of-care test Roche CARDIAC POC Troponin T (PoC TnT) is an improved assay which has been developed for the Roche cobas h 232 system.
  
  
  METHODS
  We performed a multicentre evaluation (four sites) to assess the analytical performance of the PoC TnT assay and to compare it with the central laboratory Elecsys® troponin T high sensitive (lab cTnT-hs) assay.
  
  
  RESULTS
  The relative mean differences found in method comparisons of PoC TnT vs. lab cTnT-hs ranged from -4.1% to +6.8%. Additionally, there was good concordance between PoC TnT and lab cTnT-hs for the number of samples with troponin T values below the measuring range of 40 ng/L. Lot-to-lot differences of PoC TnT ranged from -8.6% to +4.6%. Within-series coefficients of variation (CV) resulting from 81 ten-fold measurements with patient samples were 9.3%, 11.8%, and 12.9% in the low (40 to < 200 ng/L), medium (200 to < 600 ng/L), and high (600 to 2000 ng/L) measuring range, respectively. Using the system quality control, the mean CV for between-day imprecision was 11.3%. No interference was observed by triglycerides (up to 11.4 mmol/L), bilirubin (up to 376 µmol/L), hemoglobin (up to 0.12 mmol/L), biotin (up to 30 µg/L), rheumatoid factor (up to 200 IU/mL), or with 52 standard or cardiovascular drugs at therapeutic concentrations. There was no influence on the results by varying hematocrit values in a range from 25% to 53%. However, interferences with human anti-mouse antibodies were found. No significant influence on the results was found with PoC TnT by using sample volumes between 135 to 165 µL. High troponin T concentrations up to 500 µg/L did not lead to false low results, indicating no high-concentration hook effect. No cross-reactivity was found between the PoC TnT assay and human skeletal troponin T up to 1000 µg/L (< 0.05%). Diagnostic sensitivity and specificity data of a subpopulation (23 patients) of this study are in agreement with results of another large pre-hospital study.
  
  
  CONCLUSIONS
  The PoC TnT assay showed good analytical performance with excellent concordance with the calibration and reference laboratory method. It should therefore be suitable for its intended use in point-of-care settings.
authors.forename: Carsten
authors.initials: C
authors.lastname: Jungbauer
authors.forename: Julian
authors.initials: J
authors.lastname: Hupf
authors.forename: Evangelos
authors.initials: E
authors.lastname: Giannitsis
authors.forename: Johann
authors.initials: J
authors.lastname: Frick
authors.forename: Anna
authors.initials: A
authors.lastname: Slagman
authors.forename: Christoph
authors.initials: C
authors.lastname: Ehret
authors.forename: Nicolas
authors.initials: N
authors.lastname: Herbert
authors.forename: Christine
authors.initials: C
authors.lastname: Jung
authors.forename: Rainer
authors.initials: R
authors.lastname: Zerback
authors.forename: Thomas
authors.initials: T
authors.lastname: Bertsch
authors.forename: Michael
authors.initials: M
authors.lastname: Christ
mesh_terms: D000818:Animals; D015415:Biomarkers; D006801:Humans; D057230:Limit of Detection; D019095:Point-of-Care Systems; D014336:Troponin; D020107:Troponin T / Q000032:analysis*
chemical_list: D015415:Biomarkers; D014336:Troponin; D020107:Troponin T